Table 4.
Twelve-month clinical outcomes of patients presenting with ST-elevation myocardial infarction, categorized by percutaneous coronary intervention technique.
| Overall (n = 210) | Direct stenting (n = 98) | Balloon pre-dilatation stenting (n = 112) | P-value | |
|---|---|---|---|---|
| Ischemic or hemorrhagic stroke | 7 (3.33%) | 0 (0%) | 7 (6.25%) | 0.033 |
| Nonfatal MI | 10 (4.76%) | 3 (3.06%) | 7 (6.25%) | 0.448 |
| Cardiovascular death | 6 (2.86%) | 1 (1.02%) | 5 (4.46%) | 0.280 |
| Target vessel revascularization | 10 (4.76%) | 6 (6.12%) | 4 (3.57%) | 0.588 |
| Decompensated HF requiring hospitalization | 16 (7.62%) | 5 (5.10%) | 11 (9.82%) | 0.305 |
| MACE | 44 (20.95%) | 14 (14.29%) | 30 (26.79%) | 0.040 |
MI myocardial infarction, HF heart failure, MACE the composite of stroke, nonfatal myocardial infarction, revascularization, heart failure hospitalization, and cardiovascular death.